169 related articles for article (PubMed ID: 17182591)
21. The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation.
Elssner A; Vogelmeier C
Transpl Infect Dis; 2001 Sep; 3(3):168-76. PubMed ID: 11493399
[TBL] [Abstract][Full Text] [Related]
22. Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction.
Verleden SE; Ruttens D; Vos R; Vandermeulen E; Moelants E; Mortier A; Van Raemdonck DE; Proost P; Schols D; Verleden GM; Vanaudenaerde BM
Transplantation; 2015 Jan; 99(1):86-93. PubMed ID: 25050473
[TBL] [Abstract][Full Text] [Related]
23. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.
Burlingham WJ; Love RB; Jankowska-Gan E; Haynes LD; Xu Q; Bobadilla JL; Meyer KC; Hayney MS; Braun RK; Greenspan DS; Gopalakrishnan B; Cai J; Brand DD; Yoshida S; Cummings OW; Wilkes DS
J Clin Invest; 2007 Nov; 117(11):3498-506. PubMed ID: 17965778
[TBL] [Abstract][Full Text] [Related]
24. Increased levels of T cell granzyme b in bronchiolitis obliterans syndrome are not suppressed adequately by current immunosuppressive regimens.
Hodge S; Hodge G; Ahern J; Liew CL; Hopkins P; Chambers DC; Reynolds PN; Holmes M
Clin Exp Immunol; 2009 Nov; 158(2):230-6. PubMed ID: 19737140
[TBL] [Abstract][Full Text] [Related]
25. Involvement of IL-26 in bronchiolitis obliterans syndrome but not in acute rejection after lung transplantation.
Magnusson JM; Ericson P; Tengvall S; Stockfelt M; Brundin B; Lindén A; Riise GC
Respir Res; 2022 May; 23(1):108. PubMed ID: 35501858
[TBL] [Abstract][Full Text] [Related]
26. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.
Sundaresan S; Mohanakumar T; Smith MA; Trulock EP; Lynch J; Phelan D; Cooper JD; Patterson GA
Transplantation; 1998 Mar; 65(5):648-53. PubMed ID: 9521198
[TBL] [Abstract][Full Text] [Related]
27. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
[TBL] [Abstract][Full Text] [Related]
28. Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection.
Fukami N; Ramachandran S; Saini D; Walter M; Chapman W; Patterson GA; Mohanakumar T
J Immunol; 2009 Jan; 182(1):309-18. PubMed ID: 19109162
[TBL] [Abstract][Full Text] [Related]
29. Role of complement activation in obliterative bronchiolitis post-lung transplantation.
Suzuki H; Lasbury ME; Fan L; Vittal R; Mickler EA; Benson HL; Shilling R; Wu Q; Weber DJ; Wagner SR; Lasaro M; Devore D; Wang Y; Sandusky GE; Lipking K; Pandya P; Reynolds J; Love R; Wozniak T; Gu H; Brown KM; Wilkes DS
J Immunol; 2013 Oct; 191(8):4431-9. PubMed ID: 24043901
[TBL] [Abstract][Full Text] [Related]
30. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.
Slebos DJ; Postma DS; Koëter GH; Van Der Bij W; Boezen M; Kauffman HF
J Heart Lung Transplant; 2004 May; 23(5):532-40. PubMed ID: 15135367
[TBL] [Abstract][Full Text] [Related]
31. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
[TBL] [Abstract][Full Text] [Related]
32. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
[TBL] [Abstract][Full Text] [Related]
33. Early Immune Response to Acute Gastric Fluid Aspiration in a Rat Model of Lung Transplantation.
Chang JC; Finn SM; Davis RP; Sanders NL; Holzknecht ZE; Everett ML; Barbas AS; Parker W; Lin SS
Exp Clin Transplant; 2019 Feb; 17(1):84-92. PubMed ID: 29697356
[TBL] [Abstract][Full Text] [Related]
34. Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors.
Meloni F; Solari N; Miserere S; Morosini M; Cascina A; Klersy C; Arbustini E; Pellegrini C; Viganò M; Fietta AM
Transpl Immunol; 2008 Jan; 18(3):275-80. PubMed ID: 18047937
[TBL] [Abstract][Full Text] [Related]
35. Bronchiolitis obliterans syndrome: alloimmune-dependent and -independent injury with aberrant tissue remodeling.
Sato M; Keshavjee S
Semin Thorac Cardiovasc Surg; 2008; 20(2):173-82. PubMed ID: 18707652
[TBL] [Abstract][Full Text] [Related]
36. The role of autoimmunity in obliterative bronchiolitis after lung transplantation.
Weber DJ; Wilkes DS
Am J Physiol Lung Cell Mol Physiol; 2013 Mar; 304(5):L307-11. PubMed ID: 23262227
[TBL] [Abstract][Full Text] [Related]
37. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings.
Reynaud-Gaubert M; Thomas P; Badier M; Cau P; Giudicelli R; Fuentes P
Am J Respir Crit Care Med; 2000 Jun; 161(6):1924-9. PubMed ID: 10852768
[TBL] [Abstract][Full Text] [Related]
38. Obligatory role for interleukin-13 in obstructive lesion development in airway allografts.
Lama VN; Harada H; Badri LN; Flint A; Hogaboam CM; McKenzie A; Martinez FJ; Toews GB; Moore BB; Pinsky DJ
Am J Pathol; 2006 Jul; 169(1):47-60. PubMed ID: 16816360
[TBL] [Abstract][Full Text] [Related]
39. IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction.
Mikols CL; Yan L; Norris JY; Russell TD; Khalifah AP; Hachem RR; Chakinala MM; Yusen RD; Castro M; Kuo E; Patterson GA; Mohanakumar T; Trulock EP; Walter MJ
Am J Respir Crit Care Med; 2006 Aug; 174(4):461-70. PubMed ID: 16728708
[TBL] [Abstract][Full Text] [Related]
40. Circulating Exosomes with Distinct Properties during Chronic Lung Allograft Rejection.
Gunasekaran M; Sharma M; Hachem R; Bremner R; Smith MA; Mohanakumar T
J Immunol; 2018 Apr; 200(8):2535-2541. PubMed ID: 29491008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
